Bottom line
What is RAGHX's expense ratio?
RAGHX's expense ratio is 1.41%, or about $141 a year on every $10,000 invested. That is more expensive than 78% of health care sector funds we track (median 0.96%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Oct 22, 2026
RAGHX fee table
| Net expense ratio | 1.41% |
|---|---|
| Gross expense ratio | 1.41% |
| Management fee | 0.8% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.36% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 5.5% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Oct 22, 2026
What RAGHX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| RAGHX | $686 | $972 | $1,279 | $2,148 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.41% expense ratio costs roughly $75,400 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).